|
GLM |
MD&A Q1 February 29, 2024 |
MD & A (Discussion et analyse de la direction) |
26/04/2024 |
 Open Filing (872.16 Ko) |
|
GLM |
Q1 Financial Statements February 29, 2024 |
États financiers intermédiaires |
26/04/2024 |
Open Filing (385.24 Ko) |
|
GLM |
Letter to the CSE Confirming Receipt of Proceeds |
Autre |
26/04/2024 |
Open Filing (67.05 Ko) |
|
GLM |
Form 6 Certificate of Compliance |
Certificat de conformité |
26/04/2024 |
Open Filing (81.21 Ko) |
|
GLM |
Form 9 Proposed Issuance of Securities Final |
Émission proposée des titres cotés |
26/04/2024 |
Open Filing (205.25 Ko) |
|
GXP |
Form 5 - Quarterly Listing Statement |
Déclaration d'inscription trimestrielle |
26/04/2024 |
Open Filing (736.17 Ko) |
|
GXP |
Form 5 - Quarterly Listing Statement |
Déclaration d'inscription trimestrielle |
26/04/2024 |
Open Filing (692.05 Ko) |
|
CODE |
Annual MD&A |
MD & A (Discussion et analyse de la direction) |
26/04/2024 |
Open Filing (1.04 Mo) |
|
GPK |
NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES |
Émission proposée des titres cotés |
26/04/2024 |
Open Filing (180.87 Ko) |
|
CODE |
Audited Annual Financial Statements |
États financiers annuels vérifiés |
26/04/2024 |
Open Filing (667.81 Ko) |
